Quadrant Biosciences is a molecular diagnostics company with a focus on the early detection of neurological disorders and other large-scale health issues. Revolutionary  advancements in the early detection of autism spectrum disorder, Parkinson’s disease and mTBI,  through the application of the Clarifi® Dx molecular diagnostic platform, could have a significant impact on the way clinicians approach the diagnosis and treatment of these serious conditions. Clarifi ASD, an autism diagnostic aid, is the first product to launch commercially from this platform. 

Quadrant is also involved in three significant, complementary COVID-19 projects to aid in the detection of COVID-19 in individuals and communities across the U.S.

Ortho-Clinical Diagnostics is a leading provider of high-value diagnostic solutions for the global health care community. Committed to developing the most advanced tests for early detection or diagnosis of disease, the company brings products to market that provide timely information and help to facilitate better medical decisions. Ortho-Clinical Diagnostics also provides blood screening and typing products that help to ensure the safety of the world's blood supply. In addition, through its VITROS MicroSlide and enhanced chemiluminescence technologies, the company has transformed the way that clinical laboratories perform testing. Worldwide, health care professionals rely on Ortho-Clinical Diagnostics for innovative diagnostic solutions and services that promote effective diagnoses and enhance patient care.

Instant bedside confocal pathology